The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Next-Generation Sequencing (NGS) In Precision Medicine Market During The Forecast Period 2026–2030?
The next-generation sequencing (ngs) in precision medicine market size has experienced rapid growth in recent years. Its value is projected to increase from $6.42 billion in 2025 to $7.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.2%. The expansion observed historically can be ascribed to advancements in high-throughput sequencers, increasing recognition of personalized medicine, a surge in genomic research, the proliferation of bioinformatics software, and the adoption of precision medicine in clinical trials.
The next-generation sequencing (ngs) in precision medicine market is anticipated to expand significantly over the next few years, projecting an increase to $14.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.9%. This expansion is primarily propelled by advancements in sequencing instruments, the integration of artificial intelligence in genomics, the proliferation of cloud-based sequencing services, a rise in collaborations between pharmaceutical and biotech companies, and the broader adoption of precision medicine in emerging regions. Notable trends foreseen in this forecast period encompass AI-powered genomic analysis, the implementation of cloud-based sequencing solutions, the wider reach of personalized medicine, increased automation in sequencing workflows, and real-time interpretation of genomic data.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28280&type=smp
What Underlying Factors Are Accelerating The Growth Of The Next-Generation Sequencing (NGS) In Precision Medicine Market?
The growing occurrence of genetic disorders is anticipated to stimulate the expansion of the next-generation sequencing (NGS) in precision medicine market moving forward. Genetic disorders are defined as diseases or conditions stemming from abnormalities in an individual’s DNA, which can be inherited or emerge from mutations. The prevalence of genetic disorders is increasing due to advancements in diagnostic technologies, such as genetic screening and next-generation sequencing, enabling medical professionals to identify cases previously undetected, thus leading to a higher reported frequency. Next-generation sequencing in precision medicine aids in detecting genetic mutations, allowing for precise diagnoses, personalized treatments, and early interventions for these disorders. For example, in May 2024, the National Health Service, a UK-based government department, reported that approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. As a result, the increasing incidence of genetic disorders is fueling the growth of the next-generation sequencing (NGS) in precision medicine market.
What Market Segments Are Evaluated Within The Next-Generation Sequencing (NGS) In Precision Medicine Market?
The next-generation sequencing (ngs) in precision medicine market covered in this report is segmented –
1) By Product And Service: Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services
2) By Technology: Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing
3) By Application: Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics
4) By End Use: Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)
Subsegments:
1) By Sequencing Instruments: Benchtop Sequencers, High Throughput Sequencers
2) By Consumables And Reagents: Sequencing Reagents, Sequencing Chips, Flow Cells, Sample Preparation Reagents
3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits, Ribonucleic Acid (RNA) Library Preparation Kits, Whole Genome Amplification Kits, Target Enrichment Kits
4) By Bioinformatics Software: Data Analysis Software, Data Management Software, Sequence Alignment Software, Variant Calling Software
5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services, Whole Exome Sequencing Services, Targeted Sequencing Services, Ribonucleic Acid (RNA) Sequencing Services, Epigenomic Sequencing Services
What Industry Trends Are Redefining The Next-Generation Sequencing (NGS) In Precision Medicine Market?
Leading companies in the next-generation sequencing (NGS) in precision medicine market are focused on developing innovative solutions, such as multimodal DNA and RNA library kits, to enhance the efficiency and accuracy of genomic analyses. A multimodal DNA and RNA library kit is a laboratory product that enables simultaneous preparation of sequencing libraries from both DNA and RNA in a single workflow, allowing for comprehensive analysis of a sample’s genome and transcriptome. For instance, in May 2024, Qiagen N.V., a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the QIAseq Multimodal DNA and RNA Library Kit. This next-generation sequencing solution facilitates multiomic studies and advances precision medicine by enabling streamlined DNA and RNA library preparation from a single sample. The kit supports whole genome and whole transcriptome sequencing, as well as downstream target enrichment, facilitating multiomic studies by combining optimized chemistry for DNA and RNA simultaneously. It reduces the need for large sample quantities and the labor-intensive procedures found in traditional separate DNA and RNA workflows. By improving efficiency in multiomic research, this kit propels precision medicine through better biomarker discovery and disease understanding, especially in cancer research.
Who Are The Top Market Participants Influencing The Next-Generation Sequencing (NGS) In Precision Medicine Market?
Major companies operating in the next-generation sequencing (ngs) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., Singular Genomics Systems Inc.
Read the full next-generation sequencing (ngs) in precision medicine market report here:
Which Region Is Projected To Dominate The Next-Generation Sequencing (NGS) In Precision Medicine Market During The Forecast Period?
North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs) in precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Next-Generation Sequencing (NGS) In Precision Medicine Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28280&type=smp
Browse Through More Reports Similar to the Global Next-Generation Sequencing (NGS) In Precision Medicine Market 2026, By The Business Research Company
Ngs Based Rna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model